An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors

The Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). The virus has rapidly spread in humans, causing the ongoing Coronavirus pandemic. Recent studies have shown that, similarly to SARS-CoV, SARS-CoV-2 utilises th...

Descripción completa

Detalles Bibliográficos
Autores principales: Trezza, Alfonso, Iovinelli, Daniele, Santucci, Annalisa, Prischi, Filippo, Spiga, Ottavia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431416/
https://www.ncbi.nlm.nih.gov/pubmed/32807895
http://dx.doi.org/10.1038/s41598-020-70863-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431416/
https://www.ncbi.nlm.nih.gov/pubmed/32807895
http://dx.doi.org/10.1038/s41598-020-70863-9

Ejemplares similares